Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study
克拉屈滨、低剂量阿糖胞苷和维奈托克治疗新诊断和复发/难治性急性髓系白血病的疗效和安全性:单中心研究结果
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06389-9
Zhu, Ting; Wang, Li; Jiang, Hui; Huang, Shujuan; Xu, Haitao; Wang, Anyou; Liu, Xin